Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMD3100 plus G-CSF for Stem Cell Mobilization in Multiple Myeloma
NCT00103662Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jan 2005
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of plerixafor in multiple myeloma (MM), sponsored by Sanofi. Started Jan 2005; status: completed.
02
Drugs
plerixafor
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00103662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00103662.